Table 3.
Association of nephrology co-management with quality of care measures for CKD patients, stage 3 only
| Unadjusted estimatesa | Adjusted estimatesb | |||||
|---|---|---|---|---|---|---|
| Outcome | Nephrology co-management (n = 191) | Solo PCP management (n = 2363) | p value | Nephrology co-management | Solo PCP management | p value |
| Serum eGFRc | 100 % | 93 % | P < 0.0001 | 98 % | 94 % | P < 0.0001 |
| Urine protein | 88 % | 36 % | P < 0.0001 | 85 % | 34 % | P < 0.0001 |
| ACE/ARB prescription | 84 % | 65 % | P < 0.0001 | 79 % | 69 % | P = 0.02 |
| BP <140/90 mmHg | 71 % | 71 % | P = 0.93 | 71 % | 72 % | P = 0.68 |
| BP <130/80 mmHg | 48 % | 45 % | P = 0.36 | 46 % | 45 % | P = 0.96 |
| Serum LDL | 83 % | 77 % | P = 0.02 | 79 % | 78 % | P = 0.74 |
| Serum Hemoglobin or Hematocrit | 96 % | 79 % | P < 0.0001 | 96 % | 83 % | P < 0.0001 |
| Serum Calcium | 99 % | 91 % | P < 0.0001 | 99 % | 93 % | P = 0.0002 |
| Serum Phosphorus | 81 % | 18 % | P < 0.0001 | 76 % | 17 % | P < 0.0001 |
| Mean | Mean | Weighted estimate | Weighted estimate | |||
| Systolic, mmHg | 132.8 | 132.5 | P = 0.81 | 133.8 | 132.1 | P = 0.21 |
| Diastolic, mmHg | 72.7 | 72.1 | P = 0.57 | 71.9 | 72.1 | P = 0.84 |
aAll estimates account for clustering by PCP
bPercentage and p value estimated by multivariate model accounting for clustering by PCP and adjusting for age, gender, race/ethnicity, eGFR, hypertension, diabetes, and number of PCP visits
cLinear model due to 100 % rate in co-management group